JIUDIAN PHARMACEUTICAL: The JIJ02 gel is expected to complete Phase I clinical trials in the first half of next year
On September 12th, JIUDIAN PHARMACEUTICAL stated during an institutional research that, based on the current research and development progress, the JIJ02 gel is expected to complete Phase I clinical trials in the first half of next year and initiate Phase II clinical trials
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments